ERBB2 and non-small cell lung carcinoma: Some researchers have revealed that propofol restrained cell malignant phenotypes via downregulating FOXM1 through regulating the circ_RHOT1/miR-326 axis in NSCLC [19] and the circ_TADA2A/miR-155-3p axis [12] or circ_ERBB2/miR-7-5p axis [13] in lung cancer.